bis-benzimidazole has been researched along with Myotonic Dystrophy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Childs-Disney, JL; Disney, MD; Hoskins, J; Rzuczek, SG; Thornton, CA | 1 |
1 other study(ies) available for bis-benzimidazole and Myotonic Dystrophy
Article | Year |
---|---|
Rationally designed small molecules targeting the RNA that causes myotonic dystrophy type 1 are potently bioactive.
Topics: 3' Untranslated Regions; Alternative Splicing; Animals; Benzimidazoles; Cell Line; Humans; Myotonic Dystrophy; Myotonin-Protein Kinase; Nucleotide Motifs; Protein Serine-Threonine Kinases; RNA Precursors; RNA Splicing; RNA, Messenger; Small Molecule Libraries | 2012 |